SuperDerivatives announced a new product on Monday: a new revaluation investigation and analysis system (RIAS). The system “has been developed to assist customers in analysing and investigating valuations for all OTC and exchange-traded derivatives across all asset classes.”
The tool enables users to analyze the pricing assumption of individual trades and for price sensitivity comparison and stress testing of large portfolios of instruments, enhancing the level of transparency of the valuation process and helping them meet regulatory recommendations.
The launch was announced at a fund managers’ conference in Monaco. It appears that the product is largely aimed at the buy-side, providing as it does stress-testing and price-sensitivity matrices usually developed by banks’ market risk departments.
To quote again from the release: “Fund administrators are looking for an independent comparison of data based on various assumptions, an effective independent source, accurate and transparent market data, and a consistent process that could be shared with its clients. SuperDerivatives’ new service addresses these requirements.”